Patients with initially unresectable colorectal liver metastases benefit from certain induction therapies that increase surgical conversion potential. Bevacizumab plus triplet chemotherapy showed a 99% probability of improving R0-1 resection rates and progression-free survival. Bevacizumab plus doublet chemotherapy offers a more balanced benefit-risk profile, favoring safer patient outcomes. Consider adjusting induction regimens based on genetic tumor […]
Category: HPB & Spleen
Molecular insights reshape cholangiocarcinoma surgery.
Cholangiocarcinomas show significant biological diversity, influencing treatment and patient selection. High rates of actionable mutations in intrahepatic cholangiocarcinoma, such as FGFR2 fusions and IDH1/2 mutations, offer new therapeutic targets. Understanding the molecular subtypes can enhance surgical approaches and refine prognostic assessments. Tailoring surgical strategies based on molecular profiles can improve outcomes in cholangiocarcinoma patients. Review […]
Palliative Care’s Impact on End-of-Life Procedures in HPB Cancer
Incorporating palliative care can significantly impact procedural decisions for patients with hepatopancreatobiliary cancers. Among 2,848 patients, 48.2% underwent inpatient procedures; 40.7% received palliative care. Early palliative care involvement correlated with a 29% lower chance of undergoing nonpalliative procedures (odds ratio 0.71). Greater integration of palliative care may enhance decision-making aligned with patient quality of life […]
Evolving Insights on Splenectomy for Hematologic Malignancies
Splenectomy shows variable success across indications in hematologic cancers. Overall 30-day complication rate was 49%, with 22% being severe. Success rate was 91.7% for bridge-to-transplant, but only 38.5% for transfusion independence in lymphoid patients. Surgeons should evaluate the indication for splenectomy carefully, as outcomes differ significantly based on underlying conditions. Myeloid patients had a higher […]
Lymph node burden predicts recurrence patterns in cholangiocarcinoma
Tumor features after surgery for intrahepatic cholangiocarcinoma can inform recurrence risk and patient outcomes. Of 1,328 patients, 57.5% experienced recurrence: 381 had intrahepatic-only, 171 extrahepatic-only, and 165 combined recurrences. Having three or more metastatic lymph nodes increased the odds of combined recurrence by 3.47 times compared to intrahepatic-only (adjusted odds ratio). Patients with combined recurrence […]
Neoadjuvant Therapy Improves Survival After Intrahepatic Cholangiocarcinoma Resection
Neoadjuvant therapy may significantly enhance post-recurrence survival in patients with intrahepatic cholangiocarcinoma. Patients receiving neoadjuvant therapy had a median post-recurrence survival of 31.9 months compared to 16.4 months for those who did not (p = 0.006). Neoadjuvant therapy was an independent predictor of survival (hazard ratio, 0.506; p = 0.008). Consider integrating neoadjuvant therapy in […]
Examining Age Impacts Survival in Intrahepatic Cholangiocarcinoma
Younger patients with intrahepatic cholangiocarcinoma (IHC) show significantly better outcomes when unresectable compared to older patients, which may influence surgical decision-making. The median overall survival for the entire cohort was 23 months, with younger patients having longer overall survival when unresectable (p = 0.008). In the surgical group, older patients had better recurrence-free survival (27 […]
Surgeons See 10-Year Survival in Resection of Liver Metastases
Resection of solitary colorectal liver metastases leads to excellent long-term survival, but outcomes depend on lymph node status and tumor size. Median overall survival is 10 years; 52% remain recurrence-free at 3 years. Salvage therapy for 51% of recurrences boosts overall survival significantly (5.89 years vs. 2.24 years; p<0.001). Patients with more than three positive […]
Angioembolization Equals Survival to Surgery in Liver Trauma
Angioembolization offers equivalent survival rates compared to surgery for penetrating liver trauma but leads to longer hospital stays. Mortality rates were similar: 2.0% for angioembolization vs 4.8% for surgery (p = .069). Hospital stay averages: 17.3 days for angioembolization vs 11.7 days for surgery (p < .001). Identifying patients who are at higher risk for […]
Novel bile leak test shows promise in liver resection outcomes
A prospective trial indicates a new ultrasound technique may improve detection of bile leaks during liver surgery. Contrast-enhanced intraoperative ultrasonic cholangiography was technically successful in 86.2% of patients. Postoperative bile leak rate was 17.2%, with most detected intraoperatively. This approach could enhance surgical safety but requires further validation to confirm its impact on patient outcomes. […]